Call for Wider Use of New Eye Drug in Guernsey as Patients Seek Better Quality of Life
An 82-year-old Guernsey resident says patients’ quality of life is being overlooked due to cost concerns around a new treatment for wet age-related macular degeneration (AMD). Richard O’Riordan was diagnosed with wet AMD in June and now receives regular injections to protect his sight. He believes local health services should offer Vabysmo, a newer medication…